20% Prosol 0.6 g (l-Aspartic Acid LIQUID) 0.6 G

20% PROSOL 0.6 G is an intravenous solution containing L-Aspartic Acid, used for medical applications. This liquid formulation is available in 500/1000/2000 mL packs, manufactured by Baxter Corporation in Canada.

Strength

0.6 G

Pack Size

500/1000/2000ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

20% PROSOL 0.6 G is primarily used in clinical settings for intravenous administration. L-Aspartic Acid, the active ingredient, is often utilized in medical treatments where amino acid supplementation is required. This solution may be part of a broader therapeutic regimen aimed at addressing specific metabolic or nutritional needs.

Side Effects

When administered intravenously, 20% PROSOL 0.6 G delivers L-Aspartic Acid directly into the bloodstream. This can support various physiological functions, including amino acid balance. Patients may experience effects related to the body's natural processes, but individual responses can vary.

Precautions & Warnings

Handling 20% PROSOL 0.6 G requires adherence to medical guidelines for intravenous solutions. It should be administered by healthcare professionals in a controlled environment. Proper storage and preparation are essential to maintain the integrity of the solution.

Avoid Interactions

As with any intravenous solution, 20% PROSOL 0.6 G may interact with other medications or treatments. It is important to consider potential interactions with other substances, including other amino acids or supplements, to ensure safe and effective use.

Frequently Asked Questions

20% PROSOL 0.6 G is used in medical settings for intravenous administration of L-Aspartic Acid, often as part of a therapeutic regimen.

This solution is administered intravenously by healthcare professionals in a clinical setting.

The effects of 20% PROSOL 0.6 G are related to the body's natural processes, including amino acid balance.

Yes, it should be handled and administered by healthcare professionals following medical guidelines.

Potential interactions with other medications or supplements should be considered, and healthcare professionals should be consulted.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.